Integer’s (ITGR) Buy Rating Reiterated at Benchmark

Benchmark restated their buy rating on shares of Integer (NYSE:ITGR) in a research note published on Friday morning, Benzinga reports. They currently have a $130.00 price target on the medical equipment provider’s stock.

A number of other equities research analysts also recently commented on ITGR. Citigroup upped their price objective on Integer from $118.00 to $124.00 and gave the company a neutral rating in a report on Wednesday, May 22nd. KeyCorp increased their price target on Integer from $123.00 to $139.00 and gave the stock an overweight rating in a report on Tuesday, April 9th. Truist Financial assumed coverage on Integer in a report on Wednesday, May 15th. They issued a buy rating and a $137.00 price target for the company. Bank of America upgraded Integer from a neutral rating to a buy rating and increased their price target for the stock from $105.00 to $135.00 in a report on Monday, April 15th. Finally, Oppenheimer started coverage on Integer in a report on Tuesday, July 16th. They issued an outperform rating and a $135.00 price target for the company. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of Moderate Buy and a consensus price target of $133.86.

Integer Price Performance

Integer stock traded down $1.30 on Friday, reaching $110.47. The company’s stock had a trading volume of 119,762 shares, compared to its average volume of 332,633. The company has a market cap of $3.70 billion, a price-to-earnings ratio of 38.67, a PEG ratio of 1.70 and a beta of 1.11. Integer has a twelve month low of $69.40 and a twelve month high of $130.15. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29. The business’s fifty day moving average price is $118.63 and its 200 day moving average price is $113.87.

Integer (NYSE:ITGR) last released its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.06. The company had revenue of $436.20 million during the quarter, compared to the consensus estimate of $437.00 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. The firm’s quarterly revenue was up 9.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.14 earnings per share. Equities analysts expect that Integer will post 5.31 earnings per share for the current fiscal year.

Insider Buying and Selling at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of the stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the transaction, the director now owns 2,280 shares in the company, valued at $272,824.80. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Integer news, SVP Andrew Senn sold 5,000 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $113.14, for a total value of $565,700.00. Following the sale, the senior vice president now owns 4,658 shares of the company’s stock, valued at approximately $527,006.12. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jean M. Hobby sold 11,960 shares of the firm’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the completion of the sale, the director now directly owns 2,280 shares in the company, valued at approximately $272,824.80. The disclosure for this sale can be found here. Insiders have sold 28,396 shares of company stock worth $3,391,070 over the last 90 days. Company insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integer

Large investors have recently modified their holdings of the business. North Growth Management Ltd. acquired a new stake in shares of Integer in the 4th quarter valued at $9,155,000. GSA Capital Partners LLP bought a new stake in Integer during the 1st quarter worth $786,000. Public Employees Retirement Association of Colorado grew its position in Integer by 3,260.1% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider’s stock worth $28,281,000 after acquiring an additional 276,944 shares during the last quarter. Norges Bank bought a new stake in Integer during the 4th quarter worth $18,697,000. Finally, UniSuper Management Pty Ltd bought a new stake in Integer during the 1st quarter worth $976,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.